About Novelion Therapeutics Inc - NVLN

At the moment the company generates 129M USD in revenues.

On its last earning announcement, the company reported a loss of -6.06$ per share.

The book value per share is -2.38$

Novelion Therapeutics Inc - NVLN website

Create a solid portfolio with NVLN

Add NVLN to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
129M 54.30% -63M -48.90% -113M -6.06 - - 19M -2.38 -62M - -63M